The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters. - Suppr | 超能文献

The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.

作者信息

Withey R J, Feng H, Cook D, Van Petten G R, Lettau H F

出版信息

J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):187-96.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.

J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):187-96.

2

The physiologic availability of solid dosage forms of phenylbutazone. I. In vivo physiologic availability and pharmacologic considerations.

J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):177-86.

3

[Biological availability and solubility of phenylbutazone].[保泰松的生物利用度和溶解度]

Folia Med Cracov. 1979;21(1):141-7.

4

Biopharmaceutical assessment of phenylbutazone and indomethacin preparations.保泰松和吲哚美辛制剂的生物制药评估。

Ann Clin Res. 1974;6(0):suppl 11:34-43.

5

Evaluation of dosage forms. IV. Studies on commercial phenylbutazone tablet dosage forms.

Drug Dev Ind Pharm. 1998 Jul;24(7):599-604. doi: 10.3109/03639049809082360.

6

The objective and timing of drug disposition studies, appendix IV. Phenylbutazone formulations: in vitro dissolution and in vivo performance.

Drug Metab Rev. 1975;4(2):277-84. doi: 10.3109/03602537508993761.

7

The varying dissolution rates of phenylbutazone tablets.保泰松片不同的溶出速率。

N Z Med J. 1970 Oct;72(461):250-3.

8

The physiologic availability of phenylbutazone tablets marketed in India.印度市场上销售的保泰松片的生理有效性。

Int J Clin Pharmacol Ther Toxicol. 1981 Apr;19(4):163-7.

9

A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form.采用不同方法在禁食和进食状态下建立的A级体外/体内相关性：应用于固体速释口服剂型。

Eur J Pharm Sci. 2006 Jan;27(1):72-9. doi: 10.1016/j.ejps.2005.08.006. Epub 2005 Sep 19.

10

Phenylbutazone.保泰松

Pharmacology. 1972;8(1):154-63.

引用本文的文献

1

Comparative bioavailability of three brands of ampicillin.三种品牌氨苄西林的相对生物利用度

Can Med Assoc J. 1972 Aug 5;107(3):203-9.

2

Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.药物生物等效性。药物生物等效性研究小组给美国国会技术评估办公室的建议。

J Pharmacokinet Biopharm. 1974 Oct;2(5):433-66.